VYNE Therapeutics Inc.

Historical 13F Holders

Symbol
VYNE
CUSIP
92941V308
All holders as of
Q3 2026
Type
Equity
Class
COM
Reported Value, Excluding Options
Total Shares Held, Excluding Options
Total Filers

13D/G Filers

Each filer's latest filing for 92941V308 since 12/18/2024, largest first.

Filer % of Class Filed
Zhang Xiaofan 13G/A 7/17/2026
Event 6/8/2026
Under 5%, checked the "5 percent or less" box, or amended by a later filing (4)
Nantahala Capital Management, LLC 13G
Amended under CUSIP 92941V407 on 11/13/2026
6.0% 5/15/2026
Event 3/31/2026
Citadel Advisors LLC 13G/A
0% 11/14/2025
Event 9/30/2025
Cormorant Asset Management, LP 13G/A
0% 11/14/2025
Event 9/30/2025
Eventide Asset Management, LLC 13G/A
0% 11/14/2025
Event 9/30/2025

13F Holders by Quarter

Period Filers Shares, Excl. Options Value, Excl. Options
2026 Q3 1 32.0 k $721k
2026 Q2 45 14.4 M $9.40M
2026 Q1 45 14.2 M $8.46M
2025 Q4 43 9.18 M $5.32M
2025 Q3 33 3.92 M $1.32M
2025 Q2 45 8.05 M $13.3M
2025 Q1 38 7.11 M $11.4M
2024 Q4 35 7.03 M $23.3M
2024 Q3 33 7.31 M $14.3M
2024 Q2 31 7.94 M $16.0M
2024 Q1 31 7.80 M $22.8M
2023 Q4 33 7.86 M $18.3M
2023 Q3 21 360 k $1.45M
2023 Q2 20 376 k $1.53M
2023 Q1 22 336 k $1.03M